A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases. Cancer Chemother Pharmacol. 2004 Dec; 54(6):553-61.